Companies in
Pharmaceutical Industry

MoonLake Immunotherapeutics AG

Pharmaceutical Industry · Zug · Since 2021

The core activity of MoonLake Immunotherapeutics AG is the development of innovative therapies for inflammatory diseases, particularly with the goal of improving the treatment of diseases such as psoriasis and hidradenitis suppurativa. The company focuses on the development of Sonelokimab, a Nanobody that specifically inhibits interleukins to reduce inflammation. The core activities include conducting clinical trials, developing new therapies, and licensing medications.

M Swiss Finance Group Sàrl

Pharmaceutical Industry · Neuchâtel · Since 2019

Mundipharma EDO GmbH

Research & Development · Basel · Since 2013

Mundipharma Distribution GmbH

Pharmaceutical Industry · Basel · Since 2005

Mundipharma Medical GmbH

Pharmaceutical Industry · Basel · Since 2006

Mundipharma Medical GmbH is a healthcare company focused on cancer pain management and specialty care therapeutic areas, providing medicinal products and related medical support services including channels for reporting adverse events.

Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch

Pharmaceutical Industry · Basel · Since 2001

The core activity of Mundipharma is the development, manufacture and marketing of pharmaceutical products, particularly in the field of pain management for cancer patients.

MUVON Therapeutics AG

Pharmaceutical Industry · Zürich Eth-Zentrum · Since 2020

The core activity of MUVON Therapeutics AG is the development and production of muscle precursor cells for therapeutic purposes, particularly for the treatment of patients with muscle diseases. The company focuses on research and development of innovative drugs based on the use of muscle precursor cells and operates a GMP-compliant production of these cells.

Nektar Therapeutics Europe GmbH

Research & Development · Zug · Since 2021

NEURIM PHARMACEUTICALS AG

Pharmaceutical Industry · Steinhausen · Since 1999

The core activity of Neurim Pharmaceuticals is the discovery and development of innovative medications for the treatment of central nervous system (CNS) disorders, with the goal of improving the lives of patients with unmet medical needs.

NewcelX AG

Research & Development · Kloten · Since 2015

The core activity of NLS Pharmaceutics AG is the development and marketing of medications for the treatment of rare and complex central nervous system (CNS) disorders.

Nordic Pharma GmbH

Pharmaceutical Industry · Zug · Since 1997

The core activity of Nordic Pharma Schweiz is the development, manufacture and marketing of medicines, particularly in the fields of rheumatology, haematology and gynaecology. The company focuses on providing essential and hard-to-find medicines that are often neglected by larger companies.

Norgine AG

Pharmaceutical Industry · Lucerne · Since 2005

The core activity of Norgine is the development, manufacture and marketing of pharmaceutical products, in particular specialized medicines in the areas of gastroenterology, hepatology and other specialized therapeutic areas.

NOUSCOM AG

Research & Development · Basel · Since 2015

The core activity of Nouscom is the development of cancer vaccines, in particular neoantigen-based cancer vaccines for tumors with microsatellite instability.

Novartis Bioventures AG

Pharmaceutical Industry · Basel · Since 2017

Novartis Kapital AG

Pharmaceutical Industry · Basel · Since 2024

Novartis Lateinamerika AG

Pharmaceutical Industry · Basel · Since 1981

Novartis International Pharmaceutical Investment AG

Pharmaceutical Industry · Basel · Since 2017

Novartis International Pharmaceutical Investment AG is a pharmaceutical company that develops, manufactures and commercializes medicines and therapies. It conducts research and development across multiple therapeutic areas including cardiovascular, immunology, neuroscience and oncology, and supports manufacturing and distribution of products.

Novartis Overseas Investments AG

Pharmaceutical Industry · Basel · Since 2000

Novartis Pharma AG

Pharmaceutical Industry · Basel · Since 1989

Novartis Pharma AG researches, develops, manufactures and commercializes prescription medicines and therapies. It focuses on therapeutic areas including oncology, neuroscience, immunology and cardiovascular, renal and metabolic diseases, and employs technology platforms such as small‑molecule chemistry, biotherapeutics, RNA‑based approaches, radioligand therapy and gene and cell therapies.

Novartis Sanierungsstiftung

Pharmaceutical Industry · Basel · Since 2008

Novartis Stiftung für Kaderausbildung

Pharmaceutical Industry · Basel · Since 2002

Cactus Life Sciences AG

Pharmaceutical Industry · Meggen · Since 1997

Oculis Operations Sàrl

Pharmaceutical Industry · Lausanne · Since 2022

The core activity of Oculis is the development and research of innovative treatments and medications for eye diseases, particularly in the areas of Diabetic Maculopathy, dry eye, Uveitis and acute Optic Neuritis. The company focuses on developing highly effective and patient-centered solutions to improve the treatment of eye diseases and preserve patients' vision.

Onward Therapeutics SA

Pharmaceutical Industry · Epalinges · Since 2019

The core activity of Onward Therapeutics is the development of innovative cancer treatments, particularly through the identification and development of potential active substances and technologies in the field of immunotherapy and oncology. The company focuses on the development of drugs that support the immune system to fight cancer, and works with partners to develop and market transformative technologies.

Orion Pharma AG

Pharmaceutical Industry · Zug · Since 1978

The core activity of Orion Pharma AG is the development, production and marketing of pharmaceuticals for human and veterinary medicine as well as pharmaceutical excipients.

Panacea Biotec (International) SA

Pharmaceutical Industry · Zug · Since 2009

Pentapharm AG

Pharmaceutical Industry · Aesch Bl · Since 2022

The core activity of Pentapharm is the development and manufacture of innovative solutions for the diagnosis and treatment of coagulation disorders. This includes the production of diagnostic kits and reagents, peptides, enzymes and active pharmaceutical ingredients (APIs) for the pharmaceutical industry. The company focuses on the areas of haemostasis, thrombosis and bleeding and offers products and solutions for the prevention and treatment of coagulation disorders.

Perrigo Schweiz AG

Pharmaceutical Industry · Zurich · Since 1979

PETMedical AG

Medical Technology Industry · Steinhausen · Since 2009

Pharmacon AG

Management Consulting · Freienbach · Since 2013

Pharmanalytica SA

Pharmaceutical Industry · Locarno · Since 1944

Pharmotech SA

Research & Development · Eysins · Since 2018

The core activity of Pharmotech SA is the research and development of medical products based on plant-based active ingredients, particularly CBD, to combat multi-resistant bacteria (MDR-MRSA). The company focuses on researching and developing innovative solutions to combat bacteria such as Pseudomonas Aeruginosa and Staphylococcus Aureus.

Pharmunion SA

Pharmaceutical Industry · Zurich · Since 1969

The core activity of Pharmunion SA is the development, manufacture and analysis of pharmaceutical products, as well as the provision of laboratory services for B2B customers and private individuals. This includes in particular: the manufacture of pharmaceutical, chemical, biological, dietary, cosmetic and similar products; the performance of laboratory analyses and tests for pharmaceutical products; the development of innovative medicines based on research and development; and the provision of laboratory services for B2B customers and private individuals. The company is based in Switzerland and has its own certified laboratory facility.

Phialogics AG

Research & Development · Allschwil · Since 2022

Probiotical Swiss SA

Chemical Industry · Lugano · Since 2023

PTC Therapeutics Switzerland GmbH

Pharmaceutical Industry · Steinhausen · Since 2014

The company's core activity is the development, manufacture and marketing of medicines for rare diseases. The company focuses on the discovery, development and global marketing of clinically differentiated medicines for patients with rare diseases.

Red Ridge Bio AG

Pharmaceutical Industry · Basel · Since 2021

RegulaNova Sàrl

Pharmaceutical Industry · Geneva · Since 2020

Release Therapeutics SA

Research & Development · Geneva · Since 2005

The core activity of Relief Therapeutics is the development and marketing of new, patented therapeutics for rare and ultra-rare diseases, particularly for patients with severe illnesses for which there are currently no or only limited treatment options. The company focuses on developing medications for specific diseases such as Epidermolysis Bullosa, Phenylketonuria and other rare conditions.

ReMedys Foundation

Pharmaceutical Industry · Geneva · Since 2013

The core activity of ReMedys is to develop and promote innovative therapeutic approaches for patients with severe diseases without effective treatment, regardless of their commercial potential. To this end, ReMedys works in partnership with academic research institutions and industry experts to translate research results into clinical trials and develops new medicines in a project-based approach.

Rigi Therapeutics AG

Pharmaceutical Industry · Meggen · Since 2023

Roche Chemical Manufacturing and Trading Company AG

Pharmaceutical Industry · Basel · Since 2024

Roche Holding AG

Pharmaceutical Industry · Basel · Since 1966

ROELMI HPC SWISS SA

Pharmaceutical Industry · Viganello · Since 2008

Sanuman AG

Pharmaceutical Industry · Birsfelden · Since 1984

Scintec Diagnostics GmbH

Pharmaceutical Industry · Baar · Since 1997

Shield TX (Switzerland) AG

Pharmaceutical Industry · Wollerau · Since 2009

The core activity of Shield Therapeutics plc is the development and marketing of specialized pharmaceuticals, particularly for the treatment of iron deficiency, including anemia. The company focuses on developing medications that improve the lives of people with iron deficiency and has already developed a leading product called ACCRUFeR®, which is approved for the treatment of iron deficiency in adults.